Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Jiangsu Hengrui Medicine Co., Ltd.
  6. Company
    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO., LTD.

(600276)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Jiangsu Hengrui Pharmaceuticals Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical tablets, injections and raw materials. The Company's main products portfolio consists of antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents, antibiotics, specialty infusions and others. The Company distributes its products within domestic market and to overseas markets.

Number of employees : 28 903 people.
Sales per Business
20192020Delta
Anti Tumor10 575.6045.8%15 268.1055.6% +44.37%
Anesthesia5 506.5823.9%4 591.0616.7% -16.63%
Other3 935.0017.1%4 123.2915% +4.79%
Contrast Agent3 229.6214%3 630.2513.2% +12.4%
Other Business41.780.2%121.910.4% +191.8%
CNY in Million
Sales per region
20192020Delta
China22 615.1098%26 854.8097.7% +18.75%
International631.732.7%757.852.8% +19.96%
CNY in Million
Managers
Name Title Age Since
Song Zhou Chief Financial Officer 47 2016
Shuang Xue, Dr. Independent Director 50 2016
Qian Wang, Dr. Independent Director 45 2016
Jia Hong Dong, Dr. Independent Director 60 2021
Xiao Han Liu Board Secretary 35 2016
Jie Ping Sun Director & Deputy General Manager 50 -
Hong Bin Dai Director & Deputy General Manager 44 -
Lian Shan Zhang, Dr. Director & Deputy General Manager 59 2012
Su Mei Jiang Deputy General Manager 57 -
Members of the board
Name Title Age Since
Wei Dong Chairman-Supervisory Board 49 2007
Piao Yang Sun Chairman 62 2021
Jie Ping Sun Director & Deputy General Manager 50 -
Hong Bin Dai Director & Deputy General Manager 44 -
Lian Shan Zhang, Dr. Director & Deputy General Manager 59 2012
Pei Chen Li Member-Supervisory Board 34 2016
Guo Qiang Xiong Member-Supervisory Board 45 2017
Shuang Xue, Dr. Independent Director 50 2016
Qian Wang, Dr. Independent Director 45 2016
Cong Zhao Guo Director 48 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,397,477,594 3,006,493,760 47.0% 24,966,700 0.4% 47.0%
Shareholders
NameEquities%
Piao Yang Sun 1,538,184,187 24.2%
Tibet Dazi Dayuan Business Management Co. Ltd. 952,752,304 15.0%
Lianyungang Hengchuang Medical Technology Co. Ltd. 310,112,056 4.87%
China State-Owned Assets Supervision & Admn Commission 262,344,248 4.12%
Lianyungang Finance Holding Group Co. Ltd. 168,152,743 2.64%
Shanghai Youwo Technology Co. Ltd. 162,048,139 2.54%
China Securities Finance Corp. Ltd. 95,399,988 1.50%
Invesco Advisers, Inc. 82,175,352 1.29%
GF Fund Management Co., Ltd. 62,912,420 0.99%
China Investment Corp. (Investment Management) 59,118,852 0.93%
Markets and indexes
- A-share
- SSE 50 /
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  600276.SS
- Datastream Code :  
Company contact information
Jiangsu Hengrui Medicine Co., Ltd.
7 Kunlunshan Road
CN-222000 Lianyungang, Jiangsu

Phone : +86 518 81220012
Fax : +86 518 85453845
web site : http://www.hrs.com.cn
Brand Portfolio
In partnership withAllbrands.markets
More brands of Jiangsu Hengrui Medicine Co., Ltd.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
JIANGSU HENGRUI MEDICINE CO., LTD.-47.14%48 664
JOHNSON & JOHNSON1.74%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.12.71%232 621
ELI LILLY AND COMPANY41.54%215 657
MERCK & CO., INC.-4.24%198 283
ABBVIE INC.0.26%193 205
ASTRAZENECA PLC18.77%187 492
NOVARTIS AG-8.03%186 330
BRISTOL-MYERS SQUIBB COMPANY-8.21%129 683
SANOFI6.53%122 086
AMGEN INC.-11.65%118 022
GLAXOSMITHKLINE PLC3.99%96 396
ALLERGAN PLC0.97%63 659
CHUGAI PHARMACEUTICAL CO., LTD.-28.73%57 462
BAYER AG-3.20%54 575
DAIICHI SANKYO COMPANY, LIMITED-19.67%49 400
TAKEDA PHARMACEUTICAL COMPANY LIMITED-14.59%44 517
ASTELLAS PHARMA INC.24.22%32 494
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY54.41%25 318